Navigation Links
Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting

for all pre- specified patient subsets, including prior Taxotere use, geographies, and the presence or absence of pain. For each of the 20 subsets presented today, the reduction in relative risk of disease progression ranged from 26% to 46%, corresponding to hazard ratios between 0.74 and 0.54.

Disease progression in the SPARC trial was defined as the first occurrence of any of several types of progression, including radiologic tumor progression (RECIST for soft tissue lesions or two or more new lesions on a bone scan); skeletal-related events (including a bone fracture, bone surgery or initiation of bisphosphonates); symptomatic progression (pain, weight loss, worsening of performance status); or death from any cause. Approximately 37% of patients in the trial progressed by pain and approximately 36% progressed on radiologic evidence. The hazard ratio for PFS for the subset of patients with pain progression or death was 0.64 (95% CI: 0.51-0.79, p=0.0001), representing a 36% reduction in the relative risk of progression. The hazard ratio for PFS for the subset of patients with radiologic progression or death was 0.64 (95% CI: 0.51-0.81, p=0.0001), representing a 36% reduction in the relative risk of progression. The hazard ratio for PFS for the subset of patients who progressed in ways other than radiologic or pain progression was 0.86 (95% CI: 0.63-1.17, p > 0.05).

In accordance with the recommendation of the independent Data Monitoring Board for the SPARC trial, patients who have not progressed continue to be treated and all patients will be followed for overall survival. As previously communicated, the interim analysis for overall survival conducted in June 2006 showed a trend, although not statistically significant, in favor of the satraplatin arm.

PFS data as observed by the clinical site investigators were also presented today. Compared to the PFS data previously reported, these progression events were not adjudicated by the blinded indep
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
11. PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
Post Your Comments:
(Date:12/14/2009)... RIVIERA BEACH, Fla., Dec. 14 Perry ... 40 years, announces the launch of the Sigma ... advanced technology of the Sigma Elite is available ... www.perrybaromedical.com ) and has a Patent Pending. ,, ... ,, Data Capture Via Computerized System for ...
(Date:12/14/2009)... Conn., Dec. 14 Zargis Medical Corp., ... SPDE ) and a spin-off from Siemens Corporate ... that it has begun selling its award-winning Zargis ... ,, Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope ... "2009 Innovation of the Year." ...
(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that ... to announce that its affiliated fund has closed a ... in equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: ... the growth of Imaging Diagnostic Systems, Southridge has paved ... in the field of early breast cancer detection," said ...
Breaking Medicine Technology:Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2The right messenger for a healthy immune response 9284 1The right messenger for a healthy immune response 9284 2Our brain looks at eyes first to identify a face 9280 1Our brain looks at eyes first to identify a face 9280 2Our brain looks at eyes first to identify a face 9280 3US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 52116 1US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 52116 2US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 52116 3US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 52116 4
(Date:12/14/2009)... 13 years under government controlled health care, before moving to the ... engagements and in his new book, Health Reform: The End of ... a system and its threat to real health care! , ... ... a diagnostic radiologist from Minnesota, warns Americans not to sell out ...
(Date:12/14/2009)... Skilled nursing facilities (SNFs) in Ohio are making major ... with a 92 percent increase in the state-imposed Medicaid ... per bed per day, scheduled for December 15. ... an additional $17,520 to the state each month, or ... yearly. ,, Nearly 96 percent of skilled nursing facilities ...
(Date:12/14/2009)... Grubb & Ellis Healthcare REIT II, Inc. announced today that ... stockholders of record as of the close of business on ... and ending on Feb. 28, 2010. The distributions will ... and will be equal to an annualized distribution rate of ... These distributions will be aggregated and paid in cash ...
(Date:12/14/2009)... Krause, an aerospace engineer,for NASA, was giving the ... he,was confident that technology and science could solve ... one thing that science couldn,t solve.,His wife Susan ... machines,would keep her alive for awhile, she would ... 69 and is starting dialysis next month. She ...
(Date:12/14/2009)... the bump in odds is small and shouldn,t worry ... News) -- Older women who take antidepressants may have ... and death compared to women not on the medications, ... be different from clinical significance," stressed Dr. Jordan W. ... School, and lead author of a report in the ...
Breaking Medicine News(10 mins):Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3
... 19 Arabesque, an imprint of Kimani Press of ... Research Hospital(R) in conjunction with its fall book series, ... recently at a reception for the book series, which ... premier pediatric cancer research centers. Book series authors Sandra ...
... Eli Lilly and Company recently,unveiled a free pocket-sized health ... useful tips and resources to help Americans lead a,healthy life ... Organizations throughout the state of Ohio are distributing the book,to ... healthy life. , "A ...
... said the health insurance industry,s support today of national ... a requirement that every American buy insurance coverage - ... proposal amounts only to a customer delivery system for ... solve America,s health care problems and will only encourage ...
... Physicians for Human Rights (PHR) and Zimbabwean health professionals warned of ... response. , ... Cambridge, MA (Vocus) November 19, 2008 ... health professionals warned of a public health catastrophe in Zimbabwe and ...
... what you watch, when it comes to violence in ... young people, and a new paper, lead-authored by Rutgers ... violent media does indeed impact adolescent behavior. , The ... Journal of Youth and Adolescence , shows that even ...
... based drug,delivery device company announces today the company has been ... held in Scottsdale,AZ on December 10 and 11, 2008. , ... companies to present at the conference, Medipacs was,selected from 84 ... have to be highly scalable and highly defensible",said Dave Bittner, ...
Other Medicine News:Health News:Arabesque Books Donates $15,000 in Support of St. Jude in Conjunction With a New Fall Book Series 2Health News:Lilly Offers Free Health Guide, Available throughout State 2Health News:Consumer Watchdog Comments on Health Insurer's Self-Serving Support of 'Individual Mandate' 2Health News:Zimbabwean Health Workers Call For Crisis Response 2Health News:Zimbabwean Health Workers Call For Crisis Response 3Health News:Rutgers researcher's study cites media violence as 'critical risk factor' for aggression 2Health News:Rutgers researcher's study cites media violence as 'critical risk factor' for aggression 3Health News:Medipacs Chosen to Present at Invest Southwest Capital Conference 2
This large 1000 L tip makes pipetting fragile cells, genomic DNA, and viscous samples easy. Perfect for cell culture laboratories....
This 500 tip allows you to draw the full volume of compatible Biohit and Eppendorf pipettors....
200 L, Bulk, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. ...
This extra long 180 ul pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container....
Medicine Products: